# Adorx Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adorx-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Edinburgh, UK
- Website: www.adorx.com
- Total disclosed funding: $4.8M
- Latest round: Series A (Mar 9, 2018)
- Investors on record: 2

## About

Adorx Therapeutics Limited specializes in the development of innovative therapeutics, focusing on treatments for diseases through advanced biopharmaceutical solutions. The company is committed to enhancing patient outcomes with its scientific advancements.Founded in 2017 and headquartered in Edinburgh, UK, Adorx Therapeutics Limited is focused on creating groundbreaking biotherapeutics. The company raised GBP 3.50 million in Series A financing on March 9, 2018, co-led by Epidarex Capital and Sixth Element Capital, with a current valuation of GBP 6.93 million. Peter Finan serves as the CEO of the company.Adorx Therapeutics Limited primarily develops biopharmaceuticals aimed at treating various health conditions. The company's product portfolio includes innovative therapies that target specific diseases, enhancing treatment effectiveness and patient care. Its research and development efforts are geared towards creating sustainable and efficient healthcare solutions.In the most recent fiscal year 2024, Adorx Therapeutics Limited generated revenue of GBP 16,033,918.50, with an EBITDA of GBP 14,923,805. This revenue stream is indicative of the company's operational efficiency and market presence in the biopharmaceutical sector.Adorx Therapeutics Limited plans to leverage its recent Series A funding of GBP 3.50 million to advance its product development initiatives, focusing on new therapeutic solutions. The company is also targeting expansion into international markets, specifically aiming to enhance its presence in North America and Europe by late 2024. The funding will support the development of new products and the scaling of operations to meet the growing demand for innovative therapeutics.

## Funding rounds

- Series A, Mar 9, 2018, $4.8M — Epidarex Capital, Sixth Element Capital

## Investors

- Epidarex Capital (https://capitalatlas.ai/funds/epidarex-capital) — Series A
- Sixth Element Capital (https://capitalatlas.ai/funds/sixth-element-capital) — Series A